查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621469

永续製药设备市场：按类型、材料成分和最终用途划分 - 2025-2030 年全球预测

Sustainable Devices in Pharmaceutical Market by Type (Diagnostic Devices, Drug Delivery Devices, Packaging Material), Material Composition (Biodegradable Material, Recyclable Plastics, Renewable Material), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品永续器材市场规模为137.7亿美元，预计2024年将达162.1亿美元，复合年增长率为18.73%，2030年将达458.2亿美元，预计将达到1,000万美元。

由于对环保和资源高效解决方案的需求不断增长，製药业的永续设备市场正在获得越来越多的关注。该市场包括生物分解性包装、节能製造设备、可重复使用注射器和先进废弃物管理系统等产品。对永续设备的需求是由日益增加的环境合规监管压力、製药公司对企业社会责任的承诺以及社会对环境健康日益增长的关注所推动的。永续应用涵盖药品製造、包装、分销和最终用户流程。最终用途范围包括製药公司、医疗保健提供者和采用这些设备来减少生态影响并提高永续性的患者。

主要市场统计
基准年[2023] 137.7亿美元
预计年份 [2024] 162.1亿美元
预测年份 [2030] 458.2亿美元
复合年增长率（%） 18.73%

市场成长主要由绿色技术创新、研发投资增加以及製药业循环经济模式的持续采用所推动。开发具有成本效益且永续的传统製程和设备替代品的时机已经成熟。企业可以透过与高科技公司和学术机构合作来抓住这些机会，以促进创新。由于宽鬆的监管和不断发展的医疗基础设施，新兴市场提供了巨大的成长机会，为市场扩张提供了巨大的机会。

然而，它们面临着初始成本高、技术限制和保守的经营模式等挑战，这些挑战阻碍了全行业的采用。此外，检验这些设备的永续性声明也存在挑战，这可能会阻碍市场渗透。创新和研究的重点是开发可扩展且具成本效益的流程、提高设备的可回收性以及优化供应链以促进永续的商业实践。市场的本质是动态和竞争的，主要企业都投资于广泛的研究和开发，以利用新技术。透过优先考虑永续实践、加强协作和培育创新文化，企业可以获得竞争优势并在不断变化的环境中保持领先地位。

市场动态：针对药品市场快速发展的永续设备揭示的关键市场洞察

供需的动态交互作用正在改变製药领域的永续设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球对环境议题的认识不断增强
    • 交通和能源解决方案对永续设备的需求不断增长
  • 市场限制因素
    • 与环保材料相关的高成本
  • 市场机会
    • 绿色科技的持续创新提高了永续设备的效率和吸引力
    • 政府对再生能源来源和绿色技术的支持
  • 市场挑战
    • 与永续设备相关的技术限制

波特五力：驾驭永续製药设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对药品市场永续设备的影响

外部宏观环境因素在塑造製药市场永续设备的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解永续药品设备市场的竞争格局

製药市场永续设备的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在永续製药设备市场的绩效评估

FPNV 定位矩阵是评估製药市场永续设备供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和药物建议，以规划永续设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对製药市场永续设备的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球对环境议题的认识不断增强
      • 交通和能源解决方案对永续设备的需求不断增长
    • 抑制因素
      • 与环保材料相关的高成本
    • 机会
      • 绿色科技的持续创新提高了永续设备的效率和吸引力。
      • 政府对再生能源来源和绿色技术的支持
    • 任务
      • 与永续设备相关的技术限制
  • 市场区隔分析
    • 类型：可再生能源设备的日益普及和储能係统的进步
    • 最终用途：透过采用永续解决方案扩大交通和流动性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章永续製药设备市场：按类型

  • 诊断设备
  • 药物输送装置
  • 包装材料

第七章依材料成分分類的製药永续设备市场

  • 生物分解性材料
  • 可回收塑料
  • 可再生材料

第八章永续製药设备市场：依最终用途分类

  • 家庭护理设置
  • 医院/诊所

第九章美洲药品永续器材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区製药永续设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲製药的永续设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 环球电子推出尖端永续技术与软体，打造智慧生活
    • Apple 透过碳中和 Apple Watch 和绿色创新引领永续性
  • 战略分析和建议

公司名单

  • 3M Company
  • Amcor PLC
  • AptarGroup, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Fresenius SE & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Interuniversity Microelectronics Centre
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Royal Philips
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-6360D86E7072

The Sustainable Devices in Pharmaceutical Market was valued at USD 13.77 billion in 2023, expected to reach USD 16.21 billion in 2024, and is projected to grow at a CAGR of 18.73%, to USD 45.82 billion by 2030.

The market for sustainable devices in the pharmaceutical sector is gaining traction, driven by the rising demand for environmentally friendly and resource-efficient solutions. This market's scope includes products like biodegradable packaging, energy-efficient manufacturing equipment, reusable syringes, and advanced waste management systems. The necessity for sustainable devices is amplified by increasing regulatory pressure for environmental compliance, pharmaceutical companies' commitment to corporate social responsibility, and growing public concern over environmental health. Sustainable applications span across drug manufacturing, packaging, distribution, and end-user processes. End-use scope covers pharmaceutical companies, healthcare providers, and patients who are adopting these devices to reduce ecological impact and enhance sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 13.77 billion
Estimated Year [2024] USD 16.21 billion
Forecast Year [2030] USD 45.82 billion
CAGR (%) 18.73%

Market growth is primarily driven by innovation in green technologies, increasing investment in R&D, and the rising adoption of circular economy models within the pharmaceutical industry. Opportunities are ripe in developing cost-effective, sustainable alternatives to traditional processes and devices. Companies can capture these by collaborating with tech firms and academic institutions to foster innovation. Emerging markets present significant growth potential due to lenient regulations and increasing healthcare infrastructure, offering a substantial opportunity for expansion.

However, the market faces challenges such as high initial costs, technological limitations, and the slow pace of industry-wide adoption due to conservative business models. Additionally, there are challenges related to verifying the sustainability claims of these devices, which can hinder market penetration. Innovation and research are best focused on developing scalable and cost-effective processes, improving the recyclability of devices, and optimizing supply chains to foster sustainable business practices. The nature of the market is both dynamic and competitive, with key players investing in extensive R&D to harness new technologies. Companies can gain competitive advantages by prioritizing sustainable practices, advancing collaboration, and nurturing a culture of innovation to stay ahead in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sustainable Devices in Pharmaceutical Market

The Sustainable Devices in Pharmaceutical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing global consciousness about environmental issues
    • Increasing demand for sustainable devices across mobility and energy solutions
  • Market Restraints
    • High cost associated with the eco-friendly materials
  • Market Opportunities
    • Continuous innovations in green technology improve the efficiency and appeal of sustainable devices
    • Government supports for renewable energy sources and green technologies
  • Market Challenges
    • Technological limitations associated with sustainable devices

Porter's Five Forces: A Strategic Tool for Navigating the Sustainable Devices in Pharmaceutical Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sustainable Devices in Pharmaceutical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sustainable Devices in Pharmaceutical Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sustainable Devices in Pharmaceutical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sustainable Devices in Pharmaceutical Market

A detailed market share analysis in the Sustainable Devices in Pharmaceutical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sustainable Devices in Pharmaceutical Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sustainable Devices in Pharmaceutical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sustainable Devices in Pharmaceutical Market

A strategic analysis of the Sustainable Devices in Pharmaceutical Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sustainable Devices in Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Interuniversity Microelectronics Centre, Johnson & Johnson Services, Inc., Medtronic PLC, Royal Philips, Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Sustainable Devices in Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostic Devices, Drug Delivery Devices, and Packaging Material.
  • Based on Material Composition, market is studied across Biodegradable Material, Recyclable Plastics, and Renewable Material.
  • Based on End-use, market is studied across Homecare Settings and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing global consciousness about environmental issues
      • 5.1.1.2. Increasing demand for sustainable devices across mobility and energy solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the eco-friendly materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous innovations in green technology improve the efficiency and appeal of sustainable devices
      • 5.1.3.2. Government supports for renewable energy sources and green technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Technological limitations associated with sustainable devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing popularity of renewable energy devices coupled with the advancements in storage systems
    • 5.2.2. End-use: Expansion of transportation & mobility with the adoption of sustainability solutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sustainable Devices in Pharmaceutical Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic Devices
  • 6.3. Drug Delivery Devices
  • 6.4. Packaging Material

7. Sustainable Devices in Pharmaceutical Market, by Material Composition

  • 7.1. Introduction
  • 7.2. Biodegradable Material
  • 7.3. Recyclable Plastics
  • 7.4. Renewable Material

8. Sustainable Devices in Pharmaceutical Market, by End-use

  • 8.1. Introduction
  • 8.2. Homecare Settings
  • 8.3. Hospital & Clinics

9. Americas Sustainable Devices in Pharmaceutical Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sustainable Devices in Pharmaceutical Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sustainable Devices in Pharmaceutical Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Universal Electronics Inc. Unveils Cutting-Edge Sustainable Tech and Software for Smarter Living
    • 12.3.2. Apple Pioneers Sustainability with Carbon-Neutral Apple Watch and Eco-Friendly Innovations
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Amcor PLC
  • 3. AptarGroup, Inc.
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson and Company
  • 6. Boston Scientific Corporation
  • 7. Fresenius SE & Co. KGaA
  • 8. GE HealthCare Technologies Inc.
  • 9. Interuniversity Microelectronics Centre
  • 10. Johnson & Johnson Services, Inc.
  • 11. Medtronic PLC
  • 12. Royal Philips
  • 13. Siemens Healthineers AG
  • 14. Stryker Corporation
  • 15. Terumo Corporation
  • 16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET RESEARCH PROCESS
  • FIGURE 2. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET DYNAMICS
  • TABLE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLABLE PLASTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RENEWABLE MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023